
501 - 1000 employees
๐งฌ Biotechnology
๐ Pharmaceuticals
๐ฅ Funding within the last year
๐ฐ $50M Post-IPO Equity on 2026-07
Biotechnology โข Pharmaceuticals
MannKind is a biopharmaceutical company focused on transforming chronic disease care through patient-centric drug and drugโdevice combination therapies. The company develops and commercializes treatments for cardiometabolic and orphan lung diseases โ including diabetes, pulmonary hypertension, and fluid overload related to heart failure and chronic kidney disease โ and has expertise in inhalation delivery technologies (e. g. , the Afrezza inhaled insulin product and related Technosphere platform). MannKind is publicly traded (Nasdaq: MNKD) and emphasizes therapies designed to fit seamlessly into patientsโ daily lives.
๐ก We watch MannKind Corporation's careers page
Several times a day
how often we check
2
roles posted in the last 30 days
Selected: ๐บ๐ธ United States โ Remote USA.
Selected: ๐ Date Added.
๐ฅ 3 minutes ago
National Account Director securing formulary access and payer partnerships for MannKindโs biopharmaceutical treatments. Managing national accounts, launches, market access strategy, and cross-functional execution.
๐บ๐ธ United States โ Remote
๐ต $184k - $276k / year
๐ฅ Funding within the last year
๐ฐ $50M Post-IPO Equity on 2026-07
โฐ Full Time
๐ด Lead
๐งโ๐ผ Account Executive
๐ป Ghost score 0%
๐ฅ 3 minutes ago
Cardiology MSL advancing scientific engagement and medical strategy for MannKindโs cardiometabolic therapies. Supporting KOLs, research initiatives, education, and evidence-based patient care across the North Region.
๐ฝ Illinois, Iowa, +8 more states โ Remote
๐ต $148k - $222k / year
๐ฅ Funding within the last year
๐ฐ $50M Post-IPO Equity on 2026-07
โฐ Full Time
๐ก Mid-level
๐ Senior
๐ป Ghost score 0%